DiaMedica Therapeutics (NASDAQ:DMAC – Get Free Report) issued its quarterly earnings data on Monday. The company reported ($0.18) EPS for the quarter, missing the consensus estimate of ($0.17) by ($0.01), Zacks reports.
DiaMedica Therapeutics Price Performance
DMAC stock traded up $0.22 during trading on Monday, reaching $5.99. The company had a trading volume of 106,512 shares, compared to its average volume of 69,604. DiaMedica Therapeutics has a 52 week low of $2.14 and a 52 week high of $6.82. The business has a 50 day moving average of $5.95 and a 200 day moving average of $5.08. The company has a market cap of $256.14 million, a P/E ratio of -10.70 and a beta of 1.52.
About DiaMedica Therapeutics
Read More
- Five stocks we like better than DiaMedica Therapeutics
- 3 Monster Growth Stocks to Buy Now
- Can TikTok Stock Picks Really Make You Rich?
- Buy P&G Now, Before It Sets A New All-Time High
- The “Quality” Rotation: Back to Basics Investing
- 3 REITs to Buy and Hold for the Long Term
- Occidental Petroleum: 4 Reasons to Love These Prices
Receive News & Ratings for DiaMedica Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DiaMedica Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.